On 25 November 2025, Sanofi entered into a share purchase agreement to sell a 70% stake in the company operating its Lüleburgaz pharmaceutical manufacturing facility to Fareva, a world leader in industrial subcontracting for the pharmaceuticals, cosmetics, and industrial & household sectors. Sanofi will retain a 30% minority stake in the company.
The Lüleburgaz facility is one of Türkiye’s leading pharmaceutical manufacturing sites, with significant production capacity and export capabilities. The transaction is expected to close upon completion of customary regulatory approvals, including clearance from the Turkish Competition Authority.
Paksoy is pleased to announce that a team consisting of partner Stéphanie Beghe Sönmez, along with counsel Zeynep Toma and associates Selen Toma and Cansın Taner, is acting as counsel to Sanofi on this transaction.
Share
Related persons
You can contact us for detailed information.



Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
6 March 2026
Paksoy advises on Türkiye Petrolleri’s landmark USD 4 billion Sukuk Programme and inaugural USD 1 billion issuance
Paksoy is pleased to have advised on the establishment of Türkiye Petrolleri’s USD 4 billion Sukuk Issuance Programme and the successful…
27 February 2026
International Women’s Day 2026 – Women at Paksoy
At Paksoy, we believe women are fundamental to our leadership and value creation. Their contribution is not just part of our identity - it…
23 February 2026
Doğuhan Uygun and Pınar Noberi contributed to the Austrian Yearbook on International Arbitration 2026
We are pleased to announce that Doğuhan Uygun, partner, and Pınar Noberi, associate, have contributed to the Austrian Yearbook on…
18 February 2026
Once again, we are recognised among the top-tier in the Chambers Global Guide 2026
We are appreciative of the continued top-tier recognition of our firm and lawyers by the Chambers Global Guide 2026.
16 February 2026
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage.
12 February 2026
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey.
